MedTrace Logo

Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke

NCT02607943 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2016-08-19

No results posted yet for this study

Summary

Hyperglycemia is common during acute ischemic stroke. However, the optimal strategy to control hyperglycemia during acute ischemic stroke has not been established. The object of this multicenter randomized controlled study is to determine the efficacy and safety of early initiation of subcutaneous once-daily insulin glargine, in comparison with regular insulin, based on a protocolized sliding scale regimen to achieve proper sugar control in acute stroke patients with hyperglycemia admitted to the intensive care unit.

Conditions

Interventions

DRUG

Insulin Glargine

Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control

DRUG

Regular Insulin

Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • Taipei Medical University Shuang Ho Hospital

    collaborator OTHER

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Jiann-Shing Jeng, MD. PhD · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2018-07-31
Completion
2018-11-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02607943 on ClinicalTrials.gov